Header Logo

Connection

JULIE GASTIER-FOSTER to Mutation

Back to Details
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Mutation.
JULIE GASTIER-FOSTER
Connection Strength
1.646
Mutation
  1. Integrative Molecular Characterization of Malignant Pleural Mesothelioma. Cancer Discov. 2018 12; 8(12):1548-1565.
    View in: PubMed
    Score: 0.155
  2. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23; 159(3):676-90.
    View in: PubMed
    Score: 0.117
  3. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 04; 490(7418):61-70.
    View in: PubMed
    Score: 0.102
  4. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 08 14; 32(2):185-203.e13.
    View in: PubMed
    Score: 0.071
  5. Genomic characterization of cervical lymph node metastases in papillary thyroid carcinoma following the Chornobyl accident. Nat Commun. 2024 Jun 13; 15(1):5053.
    View in: PubMed
    Score: 0.057
  6. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science. 2021 05 14; 372(6543).
    View in: PubMed
    Score: 0.046
  7. Expanding the spectrum of CEP55-associated disease to viable phenotypes. Am J Med Genet A. 2020 05; 182(5):1201-1208.
    View in: PubMed
    Score: 0.042
  8. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019 03 21; 133(12):1313-1324.
    View in: PubMed
    Score: 0.039
  9. Systematic Analysis of Splice-Site-Creating Mutations in Cancer. Cell Rep. 2018 04 03; 23(1):270-281.e3.
    View in: PubMed
    Score: 0.037
  10. A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell. 2018 04 09; 33(4):690-705.e9.
    View in: PubMed
    Score: 0.037
  11. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 2018 02 12; 33(2):244-258.e10.
    View in: PubMed
    Score: 0.037
  12. Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. Nature. 2018 01 25; 553(7689):511-514.
    View in: PubMed
    Score: 0.037
  13. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell. 2017 08 14; 32(2):204-220.e15.
    View in: PubMed
    Score: 0.036
  14. Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 Nov 15; 22(22):5582-5591.
    View in: PubMed
    Score: 0.034
  15. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2016 10 04; 113(40):11306-11311.
    View in: PubMed
    Score: 0.033
  16. Development of a screening set for new (CAG/CTG)n dynamic mutations. Genomics. 1996 Feb 15; 32(1):75-85.
    View in: PubMed
    Score: 0.032
  17. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 05; 163(4):1011-25.
    View in: PubMed
    Score: 0.032
  18. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14; 374(2):135-45.
    View in: PubMed
    Score: 0.032
  19. Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nat Genet. 2015 08; 47(8):864-71.
    View in: PubMed
    Score: 0.031
  20. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18; 161(7):1681-96.
    View in: PubMed
    Score: 0.031
  21. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98.
    View in: PubMed
    Score: 0.031
  22. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29; 517(7536):576-82.
    View in: PubMed
    Score: 0.030
  23. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11; 513(7517):202-9.
    View in: PubMed
    Score: 0.029
  24. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 05 30; 368(22):2059-74.
    View in: PubMed
    Score: 0.026
  25. The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013 Mar; 45(3):279-84.
    View in: PubMed
    Score: 0.026
  26. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013 Mar; 45(3):242-52.
    View in: PubMed
    Score: 0.026
  27. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18; 487(7407):330-7.
    View in: PubMed
    Score: 0.025
  28. Quality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel. J Mol Diagn. 2011 Mar; 13(2):167-74.
    View in: PubMed
    Score: 0.023
  29. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell. 2018 04 05; 173(2):291-304.e6.
    View in: PubMed
    Score: 0.019
  30. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 04 09; 33(4):721-735.e8.
    View in: PubMed
    Score: 0.019
  31. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 02; 171(4):950-965.e28.
    View in: PubMed
    Score: 0.018
  32. A multicenter study of the frequency and distribution of GJB2 and GJB6 mutations in a large North American cohort. Genet Med. 2007 Jul; 9(7):413-26.
    View in: PubMed
    Score: 0.018
  33. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Jun 15; 169(7):1327-1341.e23.
    View in: PubMed
    Score: 0.018
  34. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017 03 13; 31(3):411-423.
    View in: PubMed
    Score: 0.017
  35. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 03 16; 543(7645):378-384.
    View in: PubMed
    Score: 0.017
  36. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. Blood. 2023 07 13; 142(2):172-184.
    View in: PubMed
    Score: 0.013
  37. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 02 23; 141(8):904-916.
    View in: PubMed
    Score: 0.013
  38. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet. 2022 09; 54(9):1376-1389.
    View in: PubMed
    Score: 0.013
  39. The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study. J Natl Cancer Inst. 2021 01 04; 113(1):27-37.
    View in: PubMed
    Score: 0.011
  40. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. Nat Cancer. 2020 11; 1(11):1113-1127.
    View in: PubMed
    Score: 0.011
  41. Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study. Circ Genom Precis Med. 2020 04; 13(2):e002480.
    View in: PubMed
    Score: 0.011
  42. Homozygous variants in AMPD2 and COL11A1 lead to a complex phenotype of pontocerebellar hypoplasia type 9 and Stickler syndrome type 2. Am J Med Genet A. 2020 03; 182(3):557-560.
    View in: PubMed
    Score: 0.010
  43. Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children. J Natl Cancer Inst. 2019 12 01; 111(12):1350-1357.
    View in: PubMed
    Score: 0.010
  44. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Rep. 2019 11 05; 29(6):1675-1689.e9.
    View in: PubMed
    Score: 0.010
  45. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019 02; 51(2):296-307.
    View in: PubMed
    Score: 0.010
  46. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes. Hum Mutat. 1999; 14(1):54-66.
    View in: PubMed
    Score: 0.010
  47. Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL. Cancer Discov. 2019 03; 9(3):436-451.
    View in: PubMed
    Score: 0.010
  48. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep. 2018 10 30; 25(5):1304-1317.e5.
    View in: PubMed
    Score: 0.010
  49. Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell. 2018 04 05; 173(2):305-320.e10.
    View in: PubMed
    Score: 0.009
  50. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell. 2018 04 05; 173(2):371-385.e18.
    View in: PubMed
    Score: 0.009
  51. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018 04 03; 23(1):239-254.e6.
    View in: PubMed
    Score: 0.009
  52. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. Cell Syst. 2018 03 28; 6(3):271-281.e7.
    View in: PubMed
    Score: 0.009
  53. Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. Blood. 2017 06 22; 129(25):3352-3361.
    View in: PubMed
    Score: 0.009
  54. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017 02 13; 31(2):181-193.
    View in: PubMed
    Score: 0.009
  55. Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia. Cancer Cell. 2016 Feb 08; 29(2):186-200.
    View in: PubMed
    Score: 0.008
  56. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28; 164(3):550-63.
    View in: PubMed
    Score: 0.008
  57. MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours. Nat Commun. 2015 Dec 04; 6:10013.
    View in: PubMed
    Score: 0.008
  58. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 08; 163(2):506-19.
    View in: PubMed
    Score: 0.008
  59. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. 2015 Mar 19; 6:6604.
    View in: PubMed
    Score: 0.008
  60. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May; 17(5):405-24.
    View in: PubMed
    Score: 0.008
  61. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell. 2015 Feb 09; 27(2):286-97.
    View in: PubMed
    Score: 0.007
  62. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012 Mar; 71(3):304-13.
    View in: PubMed
    Score: 0.006
  63. Maternal uniparental disomy of chromosome 4 in a patient with limb-girdle muscular dystrophy 2E confirmed by SNP array technology. Clin Genet. 2012 Jun; 81(6):578-83.
    View in: PubMed
    Score: 0.006
  64. Novel diagnostic features of dysferlinopathies. Muscle Nerve. 2010 Jul; 42(1):14-21.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.